Licenced doses of approved COVID-19 vaccines may not be optimal: A review of the early-phase, dose-finding trials

Although over 13 billion COVID-19 vaccine doses have been administered globally, the issue of whether the optimal doses are being used has received little attention. To address this question we reviewed the reports of early-phase dose-finding trials of the nine COVID-19 vaccines approved by World He...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunn, David T., Gilson, Richard, McCormack, Sheena, McCoy, Laura E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272950/
https://www.ncbi.nlm.nih.gov/pubmed/37355453
http://dx.doi.org/10.1016/j.vaccine.2023.06.037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272950/
https://www.ncbi.nlm.nih.gov/pubmed/37355453
http://dx.doi.org/10.1016/j.vaccine.2023.06.037

Ejemplares similares